Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells

EMBO Journal

Volumn 18, Issue 5, 1999, Pages 1367-1377

  Matsumura, Itaru ^c   Kitamura, Toshio ^a   Wakao, Hiroshi ^b   Tanaka, Hirokazu ^c   Hashimoto, Koji ^c   Albanese, Chris ^d   Downward, Julian ^e   Pestell, Richard G ^d   Kanakura, Yuzuru ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Helix Research Institute Inc   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cyclin D1; Proliferation; ras; STAT5

Indexed keywords

CYCLIN D1; INTERLEUKIN 3; MESSENGER RNA; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0033106168     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.5.1367     Document Type: Article

References (70)

1. K1Pl. Mol. Cell, Biol., 17, 3850-3857.
2. ras mutant and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem., 270, 23589-23597.
3. Arber, N., Sutter, N.T., Miyake, M., Kahn, S.M., Venkatraj, V.S., Sobrino, A., Waburton, D., Holt, P.R. and Weinstein, I.B. (1996) Increased expression of cyclin D1 and the RB tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene, 12, 1903-1908.
4. Azam, M. et al. (1995) Interleukin-3 signals through multiple isoforms of STAT5. EMBO J., 14, 1402-1411.
5. 1, Genes, Dev., 7, 812-821.
6. Brennan, P., Babbage, J.W., Burgering, B.M., Groner, B., Reif, K. and Cantrell, D.A. (1997) Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity, 7, 679-689.
7. Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W. and Darnell, J.E.,Jr (1998) Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol., 18, 2553-2558.
8. Burgering, B.M.T. and Coffer, P.J. (1995) Protein kinase B (c-akt) in phosphatidylinositol 3-kinase signal transduction. Nature, 376, 599-602.
9. Chen, J., Sadowski, H.B. and Wang, L.H. (1997) Stat5 is a physiological substrate of the insulin receptor. Proc. Natl Acad. Sci. USA, 94, 2295-2230.
10. WAF1/CIP1 mediated by STAT1. Science, 272, 719-722.
11. Chiba, S., Takaku, F., Tange, T., Shibuya, K., Misawa, C., Sasaki, K., Miyagawa, K., Yazaki, Y. and Hirai, H. (1991) Establishment and erythroid differentiation of a cytokine-dependent human leukemia cell line F-36P: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. Blood, 78, 2261-2268.
12. Chretien, S., Varlet, P., Verdier, F., Gobert, S., Crton, J.-P., Gisselbrecht, S., Mayeux, P. and Lacombe, C. (1996) Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. EMBO J., 15, 4174-4181.
13. Darnell, J.E.,Jr (1997) STATs and gene regulation. Science, 277, 1630-1635.
14. Downward, J. (1996) Control of ras activation. Cancer Surv., 27, 87-100.
15. Downward, J. (1997) Cell cycle routine role for ras. Curr. Biol., 7, 258-260.
16. 1 phase in BALB/c 3T3 cells. Mol. Cell. Biol., 14, 5441-5449.
17. Fantl, V., Stamp, G., Andrews, A., Rosewell, I. and Dickson, C. (1995) Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9, 2364-2372.
18. Feldman, G.M., Rosenthal, L.A., Liu, X., Hayes, M.P., Wynshow-Boris, A., Leonard, W.J., Hennighausen, L. and Finbloom,D.S. (1997) STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-dependent proliferation and gene expression. Blood, 90, 1768-1776.
19. Fujii, H. et al. (1995) Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc. Natl Acad. Sci. USA, 92, 5482-5486.
20. Fukada, T., Hibi, M., Yamanaka, Y., Takahashi, M., Fujitani, Y., Yumaguchi, T. Nakajima, K. and Hirano, T. (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity, 5, 449-460.
21. Gouileux, F., Pallard, C. Dusanter-Fourt, I., Wakao, H., Haldosen, L.-A., Norstedt, G., Levy, D. and Groner, B. (1995) Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J., 14, 2005-2013.
22. Ihle, J.N. (1995) Cytokine receptor signaling. Nature, 377, 591-594.
23. Ihle, J.N. (1996) Signal transducers and activators of transcription. Cell, 84, 331-334.
24. Iwatsuki, K., Endo, T. Misawa, H., Yokouchi, M., Matsumoto, A., Ohtsubo, M., Mori, K.J. and Yoshimura, A. (1997) STAT5 activation correlates with erythropoietin receptor-mediated differentiation of an erythroleukemia cell line. J. Biol. Chem., 272, 8149-8152.
25. Joneson, T., White, M.A., Wigler, M.H. and Bar-Sagi, D. (1996) Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of Ras. Science, 271, 810-812.
26. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P.H. and Downward, J. (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J., 16, 2783-2793.
27. Kitamura, T. et al. (1989) Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell Physiol., 140, 323-334.
28. Leone, G., DeGregori, J, Sears, R., Jakoi, L. and Nevins, J.R. (1997) Myc and ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature, 387, 422-426.
29. Lie, X., Robinson, G.W., Wagner, K.-W., Garrett, L., Wynshow-Boris, A. and Hennighausen, L. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev., 11, 179-186.
30. Lin, J.-X. et al. (1996) Cloning of human Stat5B: reconstitution of interleukin-2-induced Stat5A and STAT5B DNA binding activity in COS-7 cells. J. Biol. Chem., 271, 10738-10744.
31. 1 progression in NIH 3T3 cells. Mol. Cell. Biol., 15, 3654-3663.
32. Liu, X., Robinson, G.W., Gouilleux, F., Groner, B. and Hennighasen, L. (1995) Cloning and expression of STAT5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl Acad. Sci. USA, 92, 8831-8835.
33. Marshall, C.J. (1995) Specificity of receptor tyrosine kinases signaling: transient versus sustained extracellular signal-mediated kinase activation. Cell, 80, 179-185.
34. Matsumoto A., Masuhara, M., Mitsui, K., Yokouchi, M., Ohtsubo, M., Misawa, H., Miyajima, A. and Yoshimura, A. (1997) CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood, 89, 3148-3154.
35. Matsumura, I. et al. (1995) Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood, 86, 703-709.
36. Matsumura, I. et al. (1996) The biological properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. Blood, 88, 3074-3082.
37. WAF1/Cipl by STAT5. Mol. Cell. Biol., 17, 2933-2943.
38. Matsumura, I., Nakajima, K., Wakao, H., Hattori, S., Hashimoto, K., Sugahara, H., Kato, T., Miyazaki, H. and Kanakura, Y. (1998) Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol. Cell. Biol., 18, 4282-4290.
39. 1 phase of the cell cycle. Cell, 65, 701-713.
40. McCormick, F. (1994) Activators and effectors of ras p21 protein. Curr. Opin. Genet. Dev., 4, 71-76.
41. Mui, A.L.F., Wakao, H., O'Farrel, A.M., Harada, A. and Miyajima, A. (1995) Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signal through two STAT5 homologs. EMBO J., 14, 1166-1175.
42. Mui, A.L.F., Wakao, H., Kinoshita, T., Kitamura, T. and Miyajima, A. (1996) Suppression of interleukin-3-induced gene expression by a C-terminal truncated STAT5: role of STAT5 in proliferation. EMBO J., 15, 2425-2433.
43. Nakajima, H., Liu, X.-W., Wynshow-Boris, A., Osenthal, L.A., Imada, K., Finbloom, D.S., Hennighausen, L. and Leonald, W.J. (1997) An indirect effect of STAT5a in IL-2-induced proliferation: a critical role for STA5a in IL-2-mediated IL-2 receptor a chain induction. Immunity, 7, 691-701.
44. Nakajima, K., Kusafuka, T., Takeda, T., Fujitani, Y., Nakae, K. and Hirano, T. (1993) Identification of a novel interleukin-6 response element containing an ETS-binding site and a CRE-like site in the JunB promoter. Mol. Cell. Biol., 13, 3027-3041.
45. Nakajima, K. et al. (1996) A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J., 15, 3651-3658.
46. Neuhauer, H., Cumaro, A., Muller, M., Wu, H., Huffstadt, U. and Pfeffer, K. (1998) Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell, 93, 397-409.
47. Onishi, M., Nosaka, T., Misawa, K., Mui, A.L., McMahon, G.D., Miyajima, A. and Kitamura, T. (1998) Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol., 18, 3871-3879.
48. Pan, B.T., Chen, C.T. and Lin, S.M. (1994) Oncogenic ras blocks cell cycle progression and inhibits p34cdc2 kinase in activated Xenopus egg extracts. J.Biol. Chem., 269, 5968-5975.
49. Pallard, C., Gouileux, F., Benit, L., Cocault, L., Souyri, M., Levy, D., Groner, B., Gisselbrecht, S. and Dusanter-Fourt, I. (1995) Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J., 14, 2847-2856.
50. Parganas, E. et al. (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell, 93, 385-395.
51. Peeper, D.S., Upton, T.M., Ladha, M.H., Neuman, E., Zalvide, J.Z., Bernards, R., DeCaprio, J. and Ewen, M.E. (1997) Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature, 386, 177-181.
52. 1 phase in rodent fibroblasts. Genes Dev., 7, 1559-1571.
53. Quelle, F.W., Wang, D., Nosaka, T., Thierfelder, W.M., Stravopodis, D., Weinstein, J. and Ihle, J.N. (1996) Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol., 16, 1622-1631.
54. 1 phase progression: cycling on cue. Cell, 79, 551-555.
55. 1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
56. Shimozaki, K., Nakajima, K., Hirano, T. and Nagata, S. (1997) Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem., 272, 25184-25189.
57. Sugahara, H. et al. (1994) Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J. Exp. Med., 179, 1757-1766.
58. Teglund, S. et al. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell, 93, 841-850.
59. Terada, K., Kaziro, Y, and Satoh, T. (1995) Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line BaF3. J. Biol. Chem., 46, 27880-27886.
60. Turkson, J., Bowman, T., Garcia, R., Caldenhovem, E., de Groot, R.P. and Jove, R. (1998) Stat3 activation by v-Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol., 18, 2545-2552.
61. Udy, G.B., Towers, R.P., Snell, R.G., Wilkins, R.J., Park, S.-H., Ram, P.A., Waxman, D.J. and Davey, H.W. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl Acad. Sci. USA, 94, 7239-7244.
62. Wakao, H., Gouilleux, F. and Groner, B. (1994) Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J., 13, 2182-2191.
63. Wakao, H., Harada, N., Kitamura, T., Mui, A.L. and Miyajima, A. (1995) Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J., 14, 2527-2535.
64. Wakao, H., Chida, D., Damen, J.E., Krystal, G. and Miyajima, A. (1997) A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis. Biochem. Biophys. Res. Commun., 234, 198-205.
65. Watanabe, G., Richard, J., Lee, R.J., Albanese, C., Rainy, R.E., Batlle, D. and Pestell, R.G. (1996a) Angiotensin II (AII) activation of cyclin D1-dependent kinase activity. J. Biol. Chem., 271, 22570-22577.
66. Watanabe, G. et al. (1996b) Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl Acad. Sci. USA, 93, 12861-12866.
67. Watanabe, G., Albanese, C., Lee, R.J., Reutens, A., Vairo, G., Henglein, B. and Pestell, R.G. (1998) Inhibition of cyclin D1-kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell. Biol., 18, 3212-3222.
68. White, M.A., Nicolette, C., Minden, A., Polverino, A., Vanaelst, L., Karin, M. and Wigler, M.H. (1995) Multliple ras functions can contribute to mammalian-cell transformation. Cell, 80, 535-541.
69. Winston, J.T., Coats, S.R., Beach, D. and Gilman, M.Z. (1996) Regulation of the cell cycle machinery by oncogenic ras. Oncogene, 12, 127-134.
70. Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N.A., Gilbert, D.J., Copeland, N.G., Hara, T. and Miyajima, A. (1995) A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J., 14, 2816-2826.